Psychedelics Affect Far More Brain Cells Than Scientists Believed
Scientists at the University of Michigan have upended a foundational assumption about how psychedelic medicine works in the brain.
Read More
Beyond Traditional Training: How Psychedelics Are Reshaping Executive Leadership
Dr. Catriona Wallace reveals that 52% of surveyed leaders noted long-term improvements in company leadership attributed to psychedelic use.
Read More
Pharmacists Should Step Into Psychedelic Medicine as States Embrace Psilocybin Therapy
As states like New Mexico, Colorado, and Oregon legalize medical psilocybin, pharmacists are positioning themselves in this emerging field.
Read More
Democratic Congressman Says Trump Admin Signals Revolutionary Shift on Drug Policy Reform
Democratic Congressman Lou Correa believes the Trump administration presents an unprecedented opportunity to transform American drug policy.
Read More
US Armed Forces Will Start Drug Testing for Magic Mushrooms Next Month
The DoD will begin testing military personnel for psilocybin October 1st. This marks a significant expansion of the military's drug tests.
Read More
Historic Move Could Transform Psilocybin Access for Terminally Ill Patients
The DEA requested that federal health officials conduct a medical review of psilocybin - a watershed moment for psychedelic medicine.
Read More
Aspen Skier’s Remarkable Recovery: Could Psychedelics Transform Brain Injury Treatment?
Doctors predicted six months of inpatient rehabilitation, but Hall walked out in six weeks. His secret? Psychedelic mushrooms.
Read More
Breakthrough Psychedelic Drug Shows Promise in Treating Postpartum Depression
Reunion Neuroscience announced positive results from its RECONNECT Phase 2 clinical trial evaluating postpartum depression.
Read More
PharmaTher Achieves Historic Ketamine FDA Approval After Third Attempt
PharmaTher has secured FDA approval for its ketamine product KETARx, which is specifically for surgical pain management.
Read More
Trump’s VA Secretary Pushes for Psychedelic Therapy Despite Regulatory Hurdles
VA Secretary Doug Collins continues his passionate advocacy for psychedelic therapy access to achieve genuine healing for America's veterans.
Read More